[REGN] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 8.09%
YoY- 163.92%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 1,212,629 1,200,849 1,098,077 1,137,422 998,617 869,612 802,329 31.73%
PBT 292,256 330,151 227,289 393,289 327,996 276,523 221,287 20.39%
Tax 96,038 164,415 72,295 182,891 133,353 200,502 111,111 -9.26%
NP 196,218 165,736 154,994 210,398 194,643 76,021 110,176 46.97%
Tax Rate -32.86% -49.80% -31.81% -46.50% -40.66% -72.51% -50.21% -
Total Cost 1,016,411 1,035,113 943,083 927,024 803,974 793,591 692,153 29.22%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 16.18 13.80 14.12 18.50 19.49 8.74 13.73 11.57%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS 1.88 1.74 1.49 2.04 1.89 0.74 0.89 64.70%
EPS Diluted 1.69 1.59 1.34 1.82 1.69 0.66 0.79 66.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.